维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="SIDDIK Z"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase I clinical and pharmacological study of liposome-entrapped NDDP ad-ministered intrapleurally in patients with malignant pleural effusions显示文摘	PEREZ-SOLER R SHIN D M SIDDIK Z H	1997	Clin Cancer Res1997，3，3：	1
2	Cisplatin: mode of cytotoxic action and molecular basis of resistance显示文摘	SIDDIK Z H	2003	Oncogene2003，22，47：	1
3	Role of human copper transporter CTR1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells显示文摘	SONG I M SAVARAI N SIDDIK Z	2004	Mol Cancer Ther2004，3，12：	1
4	Cisplatin: mode of cytotoxic action and molecular basis of resistance显示文摘	Siddik Z H	2003	Oncogene2003，22，47：	1
5	Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamineplatinum(Ⅳ) complexes in tumor cells resistant to cisdiamminedichloroplatinum(Ⅱ) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum (Ⅳ)显示文摘	YOSHIDA M KHOKHAR A R SIDDIK Z H	1994	Cancer Res1994，54，17：	1
6	Epidermal growth factor receptor(EGFR)ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab显示文摘	Lu Y Li X Liang K Luwor R Siddik Z H Mills G B Mendelsohn J Fan Z		0，，17：	1
7	Cisplatin:mode of cytotoxic action and molecular basis of resistance显示文摘	Siddik Z H	2003	Oncogene2003，22，47：	1
8	Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities显示文摘	He G Siddik ZH Huang Z		0，，18：	1
9	Cisplatin: mode of cytotoxic action and molecular basis of resistance 显示文摘	Siddik Z	2003	Oncogene2003，22，47：	1
10	Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum (Ⅳ) complexes in tumor cells resistant to cis-diamminedichloroplatinum (Ⅱ) or trans- 1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum (Ⅳ)显示文摘	YOSHIDA M KHOKHAR A R SIDDIK Z H	1994	Cancer Res1994，54，：	1
11	Cisplatin: mode of cytotoxic action and molecular basis of resistance 显示文摘	Siddik Z H	2003	Oncogene2003，22，47：	1
12	Cisplatin:mode of cytotoxic action and molecular basis of resistance显示文摘	Z H Siddik	2003	Oncogene2003，22，：	1
13	Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin显示文摘	Newell D R Siddik Z H Gumbrell L A	1987	Eur J Cancer Clin Oncol1987，23，9：	1
14	Role of human copper transporter Ctr1 in the transport of platinum-based antitu- mor agents in cisplatin-sensitive and cisplatin-resistant cells 显示文摘	Song I S Savaraj N Siddik Z H Liu P	2004	Mol Cancer Ther2004，3，12：	1
15	Cisplatin: mode of cytotoxic action and molecular basis of resistance显示文摘	Siddik Z H	2002	Lung Cancer2002，38，：	1
16	Cisplatin:mode of eytotoxic action and molecular basis of resistance显示文摘	SIDDIK Z H	2003	Oncogene2003，22，47：	1
17	Cisplatin:mode of cytotoxic action and molecular basis of resistance显示文摘	Siddik Z H		0，，47：	1
18	Cisplatin: mode of cytotoxic action and molecular basis of resistance 显示文摘	SIDDIK Z H	2003	Oncogene2003，22，47：	1
19	Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities 显示文摘	He G Siddik ZH Huang Z	2005	Oncogene2005，24，18：	1
20	Cisplatin: Mode of cytotoxic action and molecular basis of resistance显示文摘	Siddik Z H	2003	Oncogene2003，22，47：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示